Igor J Koralnik Selected Research

oxcarbamazepine

1/2020

Risk factors for lymphopenia in patients with relapsing-remitting multiple sclerosis treated with dimethyl fumarate.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Igor J Koralnik Research Topics

Disease

27	Progressive Multifocal Leukoencephalopathy 09/2021 - 01/2002
12	Infections 09/2021 - 01/2002
12	Multiple Sclerosis 01/2021 - 04/2006
7	Immune Reconstitution Inflammatory Syndrome 05/2019 - 04/2010
5	COVID-19 06/2022 - 01/2021
5	Lymphopenia (Lymphocytopenia) 01/2020 - 10/2015
4	Viremia 01/2017 - 04/2007
3	Meningeal Tuberculosis (Tuberculous Meningitis) 12/2021 - 01/2019
3	Relapsing-Remitting Multiple Sclerosis 09/2021 - 01/2020
3	Seizures (Absence Seizure) 12/2018 - 10/2015
3	Neoplasms (Cancer) 11/2016 - 01/2002
2	Diabetes Mellitus 01/2022 - 01/2021
2	Demyelinating Diseases (Demyelinating Disease) 09/2021 - 02/2005
2	Narcolepsy 12/2019 - 01/2019
2	Inflammation (Inflammations) 01/2017 - 11/2013
2	Opportunistic Infections (Opportunistic Infection) 12/2015 - 10/2009
2	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2015 - 04/2010
2	Rheumatoid Arthritis 02/2014 - 10/2008
2	Crohn Disease (Crohn's Disease) 04/2010 - 08/2006
1	Breakthrough Infections 06/2022
1	Delirium 01/2022
1	Chronic Renal Insufficiency 01/2022
1	Coronavirus Infections 12/2021
1	Post-Acute COVID-19 Syndrome 10/2021
1	Pain (Aches) 01/2021
1	Symptom Flare Up 01/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2020
1	Disease Progression 05/2019
1	Ataxia (Dyssynergia) 01/2017
1	Glioblastoma (Glioblastoma Multiforme) 01/2017
1	Melanoma (Melanoma, Malignant) 11/2016
1	Myocarditis (Carditis) 11/2016
1	Neurologic Manifestations (Neurological Manifestations) 10/2015
1	Atrophy 08/2014
1	Cerebellar Ataxia (Dysmetria) 04/2014
1	Confusion (Bewilderment) 02/2014
1	Gliosis 11/2013
1	Persistent Infection 01/2013
1	Toxoplasmosis 09/2011

Drug/Important Bio-Agent (IBA)

16	Natalizumab (Tysabri)FDA Link 01/2020 - 01/2005
7	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 01/2002
5	EpitopesIBA 06/2008 - 01/2002
3	SteroidsIBA 01/2021 - 01/2017
3	Dimethyl FumarateIBA 01/2020 - 10/2015
3	Tumor Viral Antigens (Large T Antigen)IBA 01/2016 - 06/2008
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2021
2	OrexinsIBA 12/2019 - 01/2019
2	Interleukin-7 (Interleukin 7)IBA 01/2017 - 04/2016
2	Mirtazapine (Rexer)FDA LinkGeneric 01/2017 - 09/2007
2	Capsid Proteins (Capsid Protein)IBA 01/2016 - 08/2015
2	Proteins (Proteins, Gene)FDA Link 08/2015 - 06/2008
2	Rituximab (Mabthera)FDA Link 04/2014 - 04/2010
2	Methotrexate (Mexate)FDA LinkGeneric 02/2014 - 10/2008
2	Monoclonal AntibodiesIBA 11/2013 - 04/2010
2	Peptides (Polypeptides)IBA 01/2009 - 04/2006
1	mRNA VaccinesIBA 06/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022
1	Viral RNAIBA 01/2022
1	COVID-19 VaccinesIBA 12/2021
1	VaccinesIBA 12/2021
1	leukotriene A4 hydrolaseIBA 12/2021
1	teriflunomideIBA 09/2021
1	Immunologic Factors (Immunomodulators)IBA 09/2021
1	Antiviral Agents (Antivirals)IBA 09/2021
1	Vitamin D FDA LinkGeneric 01/2020
1	Opiate AlkaloidsIBA 01/2020
1	oxcarbamazepineIBA 01/2020
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2020
1	Carbamazepine (Tegretol)FDA LinkGeneric 01/2020
1	HLA-DQB1 antigen (HLA DQB1)IBA 12/2019
1	Filgrastim (Neupogen)FDA Link 05/2019
1	lipoarabinomannan (LAM)IBA 01/2019
1	NucleotidesIBA 01/2018
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2017
1	Mefloquine (Lariam)FDA LinkGeneric 01/2017
1	RNA (Ribonucleic Acid)IBA 01/2017
1	Methylprednisolone FDA LinkGeneric 01/2017
1	Immune Checkpoint InhibitorsIBA 11/2016
1	Pharmaceutical PreparationsIBA 11/2016
1	NivolumabIBA 11/2016
1	IpilimumabIBA 11/2016
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2016
1	FumaratesIBA 10/2015
1	Immunoglobulin M (IgM)IBA 03/2015
1	IntegrinsIBA 11/2013
1	Blood Group Antigens (Blood Groups)IBA 10/2013
1	Viral DNAIBA 01/2013
1	Protons (Proton)IBA 09/2012
1	Immunoglobulin G (IgG)IBA 10/2011
1	AntibodiesIBA 10/2011
1	ImmunosorbentsIBA 07/2011

Therapy/Procedure

11	Therapeutics 10/2021 - 10/2009
5	Highly Active Antiretroviral Therapy (HAART) 01/2016 - 01/2003
2	Aftercare (After-Treatment) 11/2016 - 09/2011
2	Immunotherapy 11/2016 - 06/2004
1	Patient Readmission 01/2021
1	Organ Transplantation 01/2021
1	Plasma Exchange 05/2019
1	Ambulatory Care (Outpatient Care) 12/2018